Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions

The Lancet

Volumn 336, Issue 8730-8731, 1990, Pages 1590-1591

  Mimms, Larry ^a   Vallari, David ^a   Ducharme, Louise ^a   Holland, Paul ^b   Kuramoto, I K ^b   Zeldis, Jerome ^c  

^a ABBOTT LABORATORIES   (United States)

^b Sacramento Medical Foundation Blood Centers   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS PROTEIN;

BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTION;

ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, VIRAL; HEPACIVIRUS; HUMAN;

EID: 0025648208     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)93377-2     Document Type: Letter

References (9)

1. Antibody to superoxide dismutase, autoimmune hepatitis and antibody tests for hepatitis C
2. False-positive anti-HCV tests in rheumatoid arthritis
3. False-positive hepatitis C virus antibody tests in paraproteinaemia
4. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?
5. Specificity of hepatitis C antibody ELISA in patients with haemophilia
6. Early US experience with anti-HCV kit in blood donors
7. Anti-HCV and transaminase testing of blood donors
8. Enzyme immunoassay system for panel testing
9. An Escherichia coli expression vector for high-level production of heterologous proteins in fusion with CMP-KDO synthetase